Loading analysis...
Loading Truth Social...
Loading live updates...
—
S&P 500— —
Nasdaq— —
Dow Jones— —
载入时间机器…
Recent NVS News Headlines
Latest news coverage for NVS aggregated from WSJ, Bloomberg, The New York Times, Financial Times, and Google News. Real-time updates, free and ad-free.
- Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis
- Novartis (NVS) Faces Another Pipeline Setback as ALS Drug Fails Mid-Stage Trial
- ETFs Investing in Novartis AG Sponsored ADR Stocks
- Novartis (NVS) Suffers its Third Drug Trial Setback in a Week, and its Worst Trading Day in Years
- Why Is Novartis Stock Trading Higher Today? - Novartis (NYSE:NVS)
- Novartis (NVS) and Ionis (IONS)’ Big Cholesterol Bet Comes Up Short in Late-Stage Trial
- Novartis halts ALS drug post mid-stage trial setback (NVS:NYSE)
- Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.
- Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
- Novartis's $30 Billion Deal Spree Triggers a Boardroom Reckoning
- Drug Trial Setbacks Raise Questions Over Novartis (NVS)’s Growth Pipeline
- Novartis investors turn spotlight on M&A after trial setbacks
- Top Investor Urges Novartis for Stronger Acquisition Oversight After M&A and Trial Setbacks
- Novartis Rebounds as $30 Billion Wipeout Draws Board Challenge
- HSBC upgrades Novartis stock rating to hold on pipeline clarity
NVS options: max pain, gamma exposure (GEX) & key levels · Search NVS in the news archive · All tickers
Settings
Appearance
Card Style
Language
Notifications
Live View Style
Trump Truth Social
About
Version
2.6.1
Data Source
r/wallstreetbets
AI Engine
ChatGPT/Gemini/Claude
MCP Server
https://mcp.sellthenews.org/mcp
Contact Us
[email protected]